AIDS
ATC code L01
Abemaciclib
Aclarubicin
Adagrasib
Adcirca
Adenosine deaminase inhibitor
Adult respiratory distress syndrome
Aflibercept
Alfred G. Gilman
Alitretinoin
Alkyl sulfonate
Alkylating antineoplastic agent
Alpelisib
Altretamine
Alvocidib
American Society of Health-System Pharmacists
Aminolevulinic acid
Aminopterin
Amrubicin
Amsacrine
Amyvid
Anaemia
Anagrelide
Anatomical Therapeutic Chemical Classification System
Anthracycline
Anthraquinone
Antifolate
Antimetabolite
Antineoplastic
Antiviral drug
Arsenic trioxide
Asparaginase
Asparagine
Atom
Atomoxetine
Atrasentan
Axicabtagene ciloleucel
Azacitidine
Aziridine
Bamlanivimab
Baqsimi
Baricitinib
Basaglar
Base-excision repair
Belinostat
Belotecan
Belzutifan
Bendamustine
Bexarotene
Biliary tract
Biological half-life
Bisantrene
Bladder cancer
Bleomycin
Board of directors
Bone marrow suppression
Bortezomib
Breast cancer
Brexucabtagene autoleucel
Busulfan
CAS Registry Number
Cabazitaxel
Camptotheca
Camptothecin
Cancer
Capecitabine
Capillary leak syndrome
Carboplatin
Carboquone
Carcinoma
Carfilzomib
Carmofur
Carmustine
Celecoxib
Cell-cycle nonspecific antineoplastic agents
ChEBI
ChEMBL
ChemSpider
Chemical formula
Chemotherapy
Chemotherapy medication
Chlorambucil
Chlormethine
Cholangiocarcinoma
Ciltacabtagene autoleucel
Cisplatin
Cladribine
Clinical trial
Clofarabine
CompTox Chemicals Dashboard
Copanlisib
Corporation
Cositecan
Crisnatol
Crosslinking of DNA
Cyclin-dependent kinase
Cyclophosphamide
Cyramza
Cytarabine
Cytidine deaminase
DNA
DNA polymerase inhibitor
DNA replication
Dacarbazine
Dactinomycin
Daunorubicin
Daunorubicin/cytarabine
Decitabine
Demecolcine
Denileukin diftitox
Deoxycytidine
Deoxycytidine deaminase
Deoxycytidine kinase
Deoxycytidine triphosphate
Deoxyribonucleotide
Diarrhea
Dicycloplatin
Dihydrofolate reductase inhibitor
Docetaxel
Doi (identifier)
Douglas R. Oberhelman
Doxifluridine
Doxorubicin
Drotrecogin alfa
DrugBank
Drug nomenclature
Drugs.com
Duloxetine
Duvelisib
ECHA InfoCard
Edema
Efaproxiral
Eflornithine
Elesclomol
Elevated transaminases
Eli Lilly and Company
Ellen R. Marram
Elsamitrucin
Emgality
Enasidenib
Endothelin receptor antagonist
Entinostat
Enzyme
Enzyme inhibitor
Epacadostat
Epirubicin
Epothilone
Erbitux
Eribulin
Estramustine phosphate
Etesevimab
Ethyl bromodifluoroacetate
Etirinotecan pegol
Etoglucid
Etoposide
Exatecan
Farnesyltransferase inhibitor
Fetal
Fever
Floxuridine
Fludarabine
Fluorine
Fluorouracil
Fluoxetine
Fotemustine
Franklyn G. Prendergast
Fuzuloparib
Gemcitabine (data page)
Gimatecan
Glasdegib
Glucagon (medication)
Glyxambi
Guide to Pharmacology
Hair loss
Halogenation
Hdl (identifier)
Hepatitis E
Histone deacetylase inhibitor
Humatrope
Humulin
Hydrazine
Hydrogen
Hydrophilic
Hydroxycarbamide
Hypomethylating agent
IMP dehydrogenase
ISBN (identifier)
IUPAC nomenclature of chemistry
Idarubicin
Idecabtagene vicleucel
Idelalisib
Ifosfamide
Imetelstat
Inavolisib
Insulin lispro
Intercalation (biochemistry)
Interferon
International Chemical Identifier
Intravenous infusion
Intravenous therapy
Irinotecan
Isocitrate dehydrogenase
Ivosidenib
Ixabepilone
Ixazomib
J. Erik Fyrwald
JSmol
Jardiance
Jaypirca
Jentadueto
John C. Lechleiter
KEGG
Kaposi sarcoma
Karen N. Horn
Kathi Seifert
Kisunla
Larotaxel
Leukopenia
Lifileucel
Lipoxygenase inhibitor
Lisocabtagene maraleucel
List of withdrawn drugs
Lomustine
Lonidamine
Losoxantrone
Lucanthone
Lurbinectedin
Lurtotecan
Lyumjev
M phase
Mannosulfan
Martin Feldstein
Masoprocol
Melphalan
Melphalan flufenamide
Menogaril
Mercaptopurine
Methotrexate
Methyl aminolevulinate
Michael L. Eskew
Microangiopathic hemolytic anemia
Microtubule
Mitobronitol
Mitoguazone
Mitomycins
Mitotane
Mitotic inhibitor
Mitoxantrone
Mitozolomide
Molar mass
NT5C
Nadofaragene firadenovec
Nausea
Navitoclax
Nedaplatin
Nelarabine
Nimustine
Niraparib
Niraparib/abiraterone acetate
Nitrogen mustard
Nitrosourea
Non-small cell lung cancer
Nucleoside
Nucleoside analogue
Obecabtagene autoleucel
Oblimersen
Off-label use
Olanzapine
Olanzapine/fluoxetine
Olaparib
Olumiant
Olutasidenib
Omacetaxine mepesuccinate
Oprozomib
Ortataxel
Orthohepevirus A
Ovarian cancer
Oxaliplatin
PARP inhibitor
PMC (identifier)
PMID (identifier)
Paclitaxel
Padeliporfin
Palbociclib
Pancreatic cancer
Panobinostat
Pegaspargase
Pemetrexed
Pentostatin
Pharmacogenetics
Pharmacogenomics
Pharmacokinetics
Phases of clinical research
Phosphate
Phosphodiesterase inhibitor
Phosphoinositide 3-kinase inhibitor
Phosphorylated
Photodynamic therapy
Photosensitizer
Pipobroman
Pirarubicin
Pixantrone
Plasma protein binding
Platinum-based antineoplastic
Plicamycin
Plitidepsin
Pneumonia
Podophyllum peltatum
Porfimer sodium
Porphyrin
Portrazza
Posterior reversible encephalopathy syndrome
Pralatrexate
Prednimustine
Pregnancy
Pregnancy category
Prescription drug
Procarbazine
Prodrug
Proteasome inhibitor
Protein kinase inhibitor
PubChem
Pulmonary edema
Purine analogue
Pyrimidine
Pyrimidine analogue
RRM1
RRM2
RRM2B
Rabacfosadine
Raloxifene
Ralph Alvarez
Raltitrexed
Ranimustine
Rash
Rate-determining step
Receptor antagonist
Regulation of therapeutic goods
Retevmo
Retinoid
Retinoid X receptor
Reyvow
Ribociclib
Ribonucleotide reductase
Ribonucleotide reductase inhibitor
Romidepsin
Route of administration
Rubitecan
Rucaparib
S2CID (identifier)
SLC28A1
SLC29A1
SLC29A2
S phase
Satraplatin
Self-replication
Seliciclib
Selinexor
Semustine
Sex steroid
Shortness of breath
Silatecan
Simplified molecular-input line-entry system
Sitimagene ceradenovec
Sotorasib
Spindle poison
Standard for the Uniform Scheduling of Medicines and Poisons
Streptomyces
Streptozotocin
Synjardy
Tabelecleucel
Tadalafil
Tagraxofusp
Talaporfin
Talimogene laherparepvec
Taltz
Taxane
Tazemetostat
Tebentafusp
Tegafur
Tegafur/gimeracil/oteracil
Temoporfin
Temozolomide
Teniposide
Teriparatide
Tesetaxel
Testicular cancer
Testolactone
Thiopurine
Thiotepa
Thrombocytopenia
Thrombotic thrombocytopenic purpura
Thymidylate synthase inhibitor
Tiazofurin
Tiazofurine
Tigilanol tiglate
Tioguanine
Tipifarnib
Tisagenlecleucel
Topoisomerase inhibitor
Topotecan
Trabectedin
Tradjenta
Treosulfan
Tretinoin
Triazene
Triaziquone
Triethylenemelamine
Trijardy
Trofosfamide
Trulicity
Type II topoisomerase
Type I topoisomerase
Umbralisib
Unique Ingredient Identifier
Uramustine
Valrubicin
Veliparib
Venetoclax
Verdinexor
Verteporfin
Verzenio
Vinblastine
Vinca alkaloid
Vincristine
Vindesine
Vinflunine
Vinorelbine
Vorasidenib
Vorinostat
Vosaroxin
WHO Model List of Essential Medicines
Wayback Machine
Winfried Bischoff
World Health Organization
Zorubicin